bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.07.22.740106

LIN-23 Affects C. elegans Pathogen and Stress Resistance by Modulating SKN-1 Activity

Abstract

During pathogen infection, the C. elegans transcription factor SKN-1 is activated through the p38 MAPK cascade to protect against oxidative damage and promote host survival. SKN-1, the functional ortholog of the mammalian Nrf family of transcription factors, participates in various biological processes and is subject to complex regulation. In this study, we identify a previously unrecognized role for LIN-23 in regulating SKN-1 during adult stress conditions. LIN-23 is an F-box protein that functions as the substrate recognition component of the Skp-Cullin-F-box (SCF) E3 ubiquitin ligase complex and has been implicated in diverse cellular processes, including cell cycle regulation, neurite outgrowth, and centrosome duplication. Although LIN-23 has previously been reported to negatively regulate SKN-1 in other contexts, our findings demonstrate that during pathogen exposure, LIN-23 acts as a positive regulator of SKN-1 activity. Specifically, loss of LIN-23 reduced SKN-1 activity and decreased survival of infected adult animals. Having established this novel relationship between LIN-23 and SKN-1, we investigated the mechanism by which LIN-23 regulates SKN-1 activity. Because SKN-1 activation occurs via the p38 MAPK signaling pathway, followed by nuclear localization, we examined whether LIN-23 influences these events, but observed no decrease in p38 MAPK phosphorylation or SKN-1 nuclear localization. Instead, we provide evidence that LIN-23 function is dependent on WDR-23, a well-established negative regulator of SKN-1. A model is proposed in which LIN-23 promotes SKN-1 activity by targeting nuclear WDR-23 for degradation. SUMMARYSKN-1 is a C. elegans transcription factor and the ortholog of mammalian Nrf proteins. Under oxidative stress conditions, including those induced by infection, SKN-1 plays a protective role. Since SKN-1 regulation is complex, understanding the mechanisms that modulate its activity is important for defining stress response pathways. The authors demonstrate that the F-box protein LIN-23 functions as a positive regulator of SKN-1. Their genetic analyses indicate that LIN-23 does not influence the canonical SKN-1 activation cascade. Instead, LIN-23 appears to regulate SKN-1 activity by modulating a negative regulator, WDR-23.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tavizon, L. A., Gabaldon, C., Cruz, M. R., Munsey, O., Garsin, D. A.. 2026-07-26. LIN-23 Affects C. elegans Pathogen and Stress Resistance by Modulating SKN-1 Activity. https://doi.org/10.64898/2026.07.22.740106

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗